Journal of Adolescent Health
Volume 43, Issue 6 , Pages 529-539 , December 2008

Economic Evaluation of Adolescent Addiction Programs: Methodologic Challenges and Recommendations

  • Jenny F. Homer, M.P.A., M.P.H.

      Affiliations

    • Health Economics Research Group, University of Miami, Coral Gables, Florida
    • ,
  • Michael F. Drummond, D.Phil.

      Affiliations

    • Centre for Health Economics, University of York, York, United Kingdom
    • ,
  • Michael T. French, Ph.D.

      Affiliations

    • Centre for Health Economics, University of York, York, United Kingdom
    • Corresponding Author InformationAddress correspondence to: Michael T. French, Ph.D., Department of Sociology, Department of Epidemiology and Public Health, and Department of Economics, 5202 University Drive, Merrick Building, Room 121F, P.O. Box 248162, Coral Gables, FL 33124-2030.

Received 24 January 2008 ,Accepted 26 June 2008.

References 

  1. Henggeler SW, Clingempeel WG, Brondino MJ, et al. Four year follow-up of multisystemic therapy with substance-abusing and substance-dependent juvenile offenders. J Am Acad Child Adolesc Psychiatry. 2002;41:868–874
  2. Liddle HA. Family-based therapies for adolescent alcohol and drug use: Research contributions and future research needs. Addiction. 2004;99(Suppl 2):76–92
  3. Muck R, Zempolich KA, Titus JC, et al. An overview of the effectiveness of adolescent substance abuse treatment models. Youth Soc. 2001;33:143–168
  4. Williams RJ, Chang SY Addiction Centre Adolescent Research Group. A comprehensive and comparative review of adolescent substance abuse treatment outcome. Clin Psychol Sci Pract. 2000;7:138–166
  5. Morral AR, Mccaffrey DF, Ridgeway G. Effectiveness of community-based treatment for substance-abusing adolescents: 12-Month outcomes of youths entering Phoenix Academy or Alternative Probation Dispositions. Psychol Addict Behav. 2004;18:257–268
  6. Hser Y, Grella CE, Hubbard RL, et al. An evaluation of drug treatments for adolescents in 4 U.S. cities. Arch Gen Psychiatry. 2001;58:689–695
  7. Dennis ML, Godley SH, Diamond G, et al. The Cannabis Youth Treatment (CYT) Study: Main findings from two randomized trials. J Subst Abuse Treat. 2004;27:197–213
  8. Dennis ML, Dawud-Noursi S, Muck R, et al. The need for developing and evaluating adolescent treatment models. In:  Stevens SJ,  Morral AR editor. Adolescent Substance Abuse Treatment in the United States: Exemplary Models from a National Evaluation Study. Binghamton, NY: Haworth Press; 2002;p. 3–34
  9. Waldron HB, Kaminer Y. On the learning curve: The emerging evidence supporting cognitive-behavioural therapies for adolescent substance abuse. Addiction. 2004;99(Suppl 2):93–105
  10. Rowe CL, Liddle HA. Treating adolescent substance abuse: State of the science. In:  Liddle HA,  Rowe CL editor. Adolescent Substance Abuse Research and Clinical Advances. New York, NY: Cambridge University Press; 2006;p. 1–22
  11. Kraft MK, Schubert K, Pond A, et al. Adolescent treatment services: The context of care. In:  Liddle HA,  Rowe CL editor. Adolescent Substance Abuse Research and Clinical Advances. New York, NY: Cambridge University Press; 2006;p. 174–188
  12. SAMSHA. National Survey on Drug Use and Health: Table G.34—Needed and Received Treatment for an Illicit Drug or Alcohol Problem in the Past Year among Persons Aged 12 or Older, by Demographic Characteristics: Percentage, 2005 and 2006 [online] Available at www.oas.samhsa.gov/NSDUH/2K6NSDUH/App.htm#TabG-34. Accessed August 14, 2008.
  13. Drummond MF, Sculpher MJ, Torrance GW, et al. Methods for the Economic Evaluation of Health Care Programmes. Oxford, UK: Oxford University Press; 2005;
  14. Sheidow AJ, Bradford WD, Henggeler SW, et al. Treatment costs for youths receiving multisystemic therapy or hospitalization after a psychiatric crisis. Psychiatr Serv. 2004;55:548–554
  15. King RD, Gaines LS, Lambert EW, et al. The co-occurrence of psychiatric and substance use diagnoses in adolescents in different service systems: Frequency, recognition, cost, and outcomes. J Behav Health Serv Res. 2000;27:417–430
  16. Foster EM, Bickman L. Refining the costs analyses of the Fort Bragg Evaluation: The impact of cost offset and cost shifting. Ment Health Serv Res. 2000;2:13–25
  17. Parthasarathy S, Weisner C. Health care services use by adolescents with intakes into an outpatient alcohol and drug treatment program. Am J Addict. 2006;15:113–121
  18. Roebuck MC, French MT, McLellan AT. DATStats: Summary results from 85 completed Drug Abuse Treatment Cost Analysis Programs (DATCAPs). J Subst Abuse Treat. 2003;25:51–57
  19. Zavala S, French MT, Henderson CE, et al. Guidelines and challenges for estimating the economic costs and benefits of adolescent substance abuse treatments. J Subst Abuse Treat. 2005;29:191–205
  20. Balsa A, Homer J, French M, et al. Substance use, education, employment, and criminal activity outcomes of adolescents in outpatient chemical dependency programs. J Behav Health Serv Res (in press).
  21. Freeborn DK, Beaudet MP, Mullooly JP, et al. Adolescent chemical dependency treatment in an HMO. HMO Pract. 1991;5:44–50
  22. Koenig L, Denmead G, Nguyen R, et al. The Costs and Benefits of Substance Abuse Treatment: Findings from the National Treatment Improvement Evaluation Study (NTIES). Rockville, MD: Center for Substance Abuse Treatment; 1999;
  23. French MT, Zavala SK, McCollister KE, Waldron , et al. Cost-effectiveness analysis (CEA) of four interventions for adolescents with a substance use disorder. J Subst Abuse Treat. 2008;34:272–281
  24. McCollister KE, French MT, Sheidow A, et al. Estimating the differential costs of criminal activity among juvenile drug court participants: Challenges and recommendations. J Behav Health Serv Res (in press).
  25. French MT, Roebuck MC, Dennis ML, et al. Outpatient marijuana treatment for adolescents—economic evaluation of a multisite experiment. Eval Rev. 2003;27:421–459
  26. Schoenwald SK, Ward DM, Henggeler SW, et al. Multisystemic therapy treatment of substance abusing or dependent adolescent offenders: Costs of reducing incarceration, inpatient, and residential placement. J Child Fam Stud. 1996;5:431–444
  27. Brown SA. Measuring youth outcomes from alcohol and drug treatment. Addiction. 2004;99(Suppl 2):38–46
  28. Aarons G, Brown S, Hough R, et al. Prevalence of adolescent substance use disorders across five sectors of care. J Am Acad Child Adolesc Psychiatry. 2001;40:419–426
  29. Parkin M. Microeconomics. 7th Edition. Boston, MA: Pearson Education; 2005;
  30. Guyatt GH, Haynes RB, Jaeschke RZ, et al. for the Evidence-Based Medicine Working Group. Users’ guides to the medical literature XXV. Evidence-based medicine: Principles for applying the users’ guides to patient care. JAMA. 2000;284:1290–1296
  31. Heckman JJ. Randomization as an instrumental variable. Rev Econ Stat. 1996;78:336–341
  32. Friis RH, Sellers TA. Epidemiology for Public Health Practice. 3rd edition. Boston, MA: Jones and Bartlett Publishers; 2003;
  33. Godley MD, Godley SH, Dennis ML, et al. Preliminary outcomes from the assertive continuing care experiment for adolescents discharged from residential treatment. J Subst Abuse Treat. 2002;23:21–32
  34. Liddle HA, Dakof GA, Parker K. Multidimensional family therapy for adolescent substance abuse: Results of a randomized controlled trial. Am J Drug Alcohol Abuse. 2001;27:651–658
  35. Waldron HB, Slesnick NM, Brody JL, et al. Treatment outcomes for adolescent substance abuse at 4- and 7-month assessments. J Consult Clin Psychol. 2001;69:802–813
  36. Schulz KF, Chalmers I, Hayes RJ, et al. Empirical evidence of bias: Dimensions of methodologic quality associated with estimates of treatment effects in controlled trials. JAMA. 1995;273:408–412
  37. Brown SA, D'Amico EJ, McCarthy DM, et al. Four-year outcomes from adolescent alcohol and drug treatment. J Stud Alcohol. 2001;62:381–388
  38. Godley SH, Dennis ML, Godley MD, et al. Thirty-month relapse trajectory cluster groups among adolescents discharged from out-patient treatment. Addiction. 2004;99(Suppl 2):129–139
  39. Chung T, Maisto SA, Cornelius JR, et al. Adolescents' alcohol and drug use trajectories in the year following treatment. J Stud Alcohol. 2004;65:105–114
  40. Dennis ML, Scott CK, Funk R, et al. The duration and correlates of addiction and treatment careers. J Subst Abuse Treat. 2005;28(Suppl 1):S51–S62
  41. Donner A. Some aspects of the design and analysis of cluster randomization trials. J R Stat Soc Ser C Appl Stat. 1998;47:95–113
  42. Gil AG, Wagner EF, Tubman JG. Culturally sensitive substance abuse intervention for Hispanic and African American adolescents: Empirical examples from the Alcohol Treatment Targeting Adolescents in Need (ATTAIN) Project. Addiction. 2004;99(Suppl 2):140–150
  43. McClellan M, McNeil BJ, Newhouse JP. Does more intensive treatment of acute myocardial infarction in the elderly reduce mortality?. JAMA. 1994;272:859–866
  44. Goldman DP, Bhattacharya J, McCaffrey DF, et al. Effect of insurance on mortality in an HIV-positive population in care. J Am Stat Assoc. 2001;96:883–894
  45. Buxton MJ, Drummond MF, Van Hout BA, et al. Modeling in economic evaluation: An unavoidable fact of life. Health Econ. 1997;6:217–227
  46. Mark DB, Hlatky MA, Califf RM, et al. Cost-effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction. N Engl J Med. 1995;332:1418–1424
  47. French MT, Roebuck MC, Dennis ML, et al. The economic cost of outpatient marijuana treatment for adolescents: Findings from a multi-site field experiment. Addiction. 2002;97(Suppl 1):84–97
  48. Salome HJ, French MT, Miller M, et al. Estimating the client costs of addiction treatment: First findings from the Client Drug Abuse Treatment Cost Analysis Program (Client DATCAP). Drug Alcohol Depend. 2003;71:195–206
  49. Borisova NN, Goodman AC. Measuring the value of time for methadone maintenance clients: Willingness to pay, willingness to accept, and the wage rate. Health Econ. 2003;12:323–334
  50. Kirby KC, Dugosh KL, Benishek LA, et al. The significant other checklist: Measuring the problems experienced by family members of drug users. Addict Behav. 2005;30:29–47
  51. Grella CE, Hser Y, Joshi V, et al. Drug treatment outcomes for adolescents with comorbid mental and substance use disorders. J Nerv Ment Dis. 2001;189:384–392
  52. Whitmore EA, Mikulich SK, Ehlers KM, et al. One-year outcome of adolescent females referred for conduct disorder and substance abuse/dependence. Drug Alcohol Depend. 2000;59:131–141
  53. Cohen MA. The monetary value of saving a high-risk youth. J Quantitat Criminol. 1998;14:5–33
  54. Sindelar JL, Jofre-Bonet M, French MT, et al. Cost-effectiveness analysis of addiction treatment: Paradoxes of multiple outcomes. Drug Alcohol Depend. 2004;73:41–50
  55. Domino ME, Burns BJ, Silva SG, et al. Cost-effectiveness of treatments for adolescent depression: Results from TADS. Am J Psychiatry. 2008;165:588–596
  56. Lynch FL, Hornbrook M, Clarke GN, et al. Cost-effectiveness of an intervention to prevent depression in at-risk teens. Arch Gen Psychiatry. 2005;62:1241–1248
  57. Mauskopf JA, Paul JE, Grant DM, et al. The role of cost-consequence analysis in health care decision making. Pharmacoeconomics. 1998;13:277–288
  58. Ettner SL, Huang D, Evans E, et al. Benefit cost in the California treatment outcome project: Does substance abuse treatment pay for itself?. Health Serv Res. 2006;41:192–213
  59. Olmstead TA, Sindelar JL, Petry NM. Cost-effectiveness of prize-based incentives for stimulant abusers in outpatient psychosocial treatment programs. Drug Alcohol Depend. 2007;87:175–182
  60. Henggeler SW, Pickrel SG, Brondino MJ. Multisystemic treatment of substance abusing and dependent delinquents: Outcomes, treatment fidelity, and transportability. Ment Health Serv Res. 1999;1:171–184

PII: S1054-139X(08)00305-4

doi: 10.1016/j.jadohealth.2008.06.022

Journal of Adolescent Health
Volume 43, Issue 6 , Pages 529-539 , December 2008

Article Tools